Skip to main content
Robin Dore, MD, Rheumatology, Tustin, CA

Robin K Dore MD

Rheumatology•Tustin, CA

Rheumatoid Arthritis & Related, Spondyloarthropathy

Clinical Professor of Medicine, UCLA

Join to view full profile

  • 12791 Newport AveSte 201Tustin, CA 92780

  • Phone+1 714-505-5500

  • Fax+1 714-505-3381

Dr. Dore is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Dore's full profileAlready have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1978 - 1980
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1976 - 1978
  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1975 - 1976
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 1974
  • Pomona College
    Pomona CollegeB.S, 1967 - 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1976 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2012, 2014-2017
  • Top Doctors:LA Area Castle Connolly, 2013

Publications & Presentations

PubMed

Journal Articles

  • Osteoporosis: Fractures and Key Risk Factors.  
    Dore RK, Female Patient; March Supp:5-12
  • Guidelines for Rheumatology Referral.  
    Dore RK, et al, American College of Rheumatology
  • Efficacy and Safety of Etodolac and Naproxen in Patients with Osteoarthritis of the Knee: A Double-Blind, Placebo Controlled Study.  
    Dore RK, et al, Clinical Therapeutics, Vol. 17, No 4, 656-666

Books/Book Chapters

  • Arthritis: your comprehensive guide to pain management, medication, diet, exercise, surgery, and physical therapies. 
    Bird H, Green C et al. US Consultant: Dore RKDK Publishing, New York
  • Bone Disease in Rheumatology. 
    Chapter: The Use of Parathyroid Hormone in Patients with Rheumatic Diseases 
    Dore RKEditors: Maricic MJ, Gluck 0.Lippincott Williams & Wilkins, Philadelphia, PA
  • Treatment of the Rheumatic Disease. 
    Chapter: Developing Medical Documentation for Rheumatology Encounters 
    Locks CD, Dore RKEditors: Weisman M, Weinblatt M, Louie J.WB Saunders, Philadelphia, PAEdition 2nd,

Abstracts/Posters

  • Denosumab Increases Bone Mineral Density in Patients With Rheumatoid Arthritis: 12-month Results.
    Dore R et al, ASBMR
  • Inhibiting RANKL with Denosumab Increases Bone Mineral Density in Patients with Rheumatoid Arthritis: 6month results from a randomized, placebo-controlled study.
    Dore RK et al, EULAR
  • RANKL Inhibition with Denosumab Increases Bone Mineral Density in Patients with Rheumatoid Arthritis.
    Dore RK et al, ECCEO, Porto, Portugal

Authored Content

  • Evidence-Based Medicine Is Not Evident in the New American College of Rheumatology Guidelines for Glucocorticoid-Induced OsteoporosisNovember 2022

Press Mentions

  • Webinar: What Do These Numbers Mean? Decoding Your Arthritis Labs
    Webinar: What Do These Numbers Mean? Decoding Your Arthritis LabsAugust 9th, 2019
  • Sandoz Will Appeal District Court of New Jersey Ruling in Biosimilar Erelzi (Etanercept-Szzs) US Patent Case
    Sandoz Will Appeal District Court of New Jersey Ruling in Biosimilar Erelzi (Etanercept-Szzs) US Patent CaseAugust 9th, 2019
  • Three Medical Groups Join Push to Lower Drug Prices
    Three Medical Groups Join Push to Lower Drug PricesJune 21st, 2017

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Robin Dore, Dr. Robin Dore, MD, Dr. R Dore, Dr. Robin K Dore